vs
Krystal Biotech, Inc.（KRYS）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
Krystal Biotech, Inc.的季度营收约是REGIS CORP的1.9倍（$107.1M vs $57.1M），Krystal Biotech, Inc.净利率更高（48.0% vs 0.8%，领先47.2%），REGIS CORP同比增速更快（22.3% vs 17.5%），Krystal Biotech, Inc.自由现金流更多（$75.4M vs $891.0K），过去两年Krystal Biotech, Inc.的营收复合增速更高（53.8% vs 7.8%）
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
KRYS vs RGS — 直观对比
营收规模更大
KRYS
是对方的1.9倍
$57.1M
营收增速更快
RGS
高出4.7%
17.5%
净利率更高
KRYS
高出47.2%
0.8%
自由现金流更多
KRYS
多$74.5M
$891.0K
两年增速更快
KRYS
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $107.1M | $57.1M |
| 净利润 | $51.4M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 41.5% | 10.8% |
| 净利率 | 48.0% | 0.8% |
| 营收同比 | 17.5% | 22.3% |
| 净利润同比 | 13.0% | -94.0% |
| 每股收益（稀释后） | $1.69 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRYSRGS
| Q4 25 | $107.1M | $57.1M | ||
| Q3 25 | $97.8M | $59.0M | ||
| Q2 25 | $96.0M | $60.4M | ||
| Q1 25 | $88.2M | $57.0M | ||
| Q4 24 | $91.1M | $46.7M | ||
| Q3 24 | $83.8M | $46.1M | ||
| Q2 24 | $70.3M | $49.4M | ||
| Q1 24 | $45.3M | $49.2M |
净利润KRYSRGS
| Q4 25 | $51.4M | $456.0K | ||
| Q3 25 | $79.4M | $1.4M | ||
| Q2 25 | $38.3M | $116.5M | ||
| Q1 25 | $35.7M | $250.0K | ||
| Q4 24 | $45.5M | $7.6M | ||
| Q3 24 | $27.2M | $-853.0K | ||
| Q2 24 | $15.6M | $91.2M | ||
| Q1 24 | $932.0K | $-2.3M |
营业利润率KRYSRGS
| Q4 25 | 41.5% | 10.8% | ||
| Q3 25 | 42.3% | 10.0% | ||
| Q2 25 | 40.9% | 12.1% | ||
| Q1 25 | 41.0% | 8.8% | ||
| Q4 24 | 45.4% | 11.8% | ||
| Q3 24 | 26.8% | 4.6% | ||
| Q2 24 | 12.2% | — | ||
| Q1 24 | -14.8% | 8.3% |
净利率KRYSRGS
| Q4 25 | 48.0% | 0.8% | ||
| Q3 25 | 81.2% | 2.3% | ||
| Q2 25 | 39.9% | 192.9% | ||
| Q1 25 | 40.5% | 0.4% | ||
| Q4 24 | 49.9% | 16.4% | ||
| Q3 24 | 32.4% | -1.9% | ||
| Q2 24 | 22.2% | 184.7% | ||
| Q1 24 | 2.1% | -4.7% |
每股收益（稀释后）KRYSRGS
| Q4 25 | $1.69 | $0.16 | ||
| Q3 25 | $2.66 | $0.49 | ||
| Q2 25 | $1.29 | $43.67 | ||
| Q1 25 | $1.20 | $0.08 | ||
| Q4 24 | $1.53 | $2.71 | ||
| Q3 24 | $0.91 | $-0.36 | ||
| Q2 24 | $0.53 | $38.40 | ||
| Q1 24 | $0.03 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $496.3M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $1.2B | $188.7M |
| 总资产 | $1.3B | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资KRYSRGS
| Q4 25 | $496.3M | $18.4M | ||
| Q3 25 | $392.6M | $16.6M | ||
| Q2 25 | $353.8M | $17.0M | ||
| Q1 25 | $308.8M | $13.3M | ||
| Q4 24 | $344.9M | $10.2M | ||
| Q3 24 | $374.0M | $6.3M | ||
| Q2 24 | $345.8M | $10.1M | ||
| Q1 24 | $359.0M | $5.9M |
总债务KRYSRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益KRYSRGS
| Q4 25 | $1.2B | $188.7M | ||
| Q3 25 | $1.1B | $187.6M | ||
| Q2 25 | $1.0B | $185.6M | ||
| Q1 25 | $984.7M | $68.6M | ||
| Q4 24 | $946.4M | $66.7M | ||
| Q3 24 | $885.8M | $56.4M | ||
| Q2 24 | $838.9M | $56.8M | ||
| Q1 24 | $799.2M | $-35.8M |
总资产KRYSRGS
| Q4 25 | $1.3B | $588.3M | ||
| Q3 25 | $1.2B | $592.1M | ||
| Q2 25 | $1.1B | $599.0M | ||
| Q1 25 | $1.1B | $511.2M | ||
| Q4 24 | $1.1B | $530.1M | ||
| Q3 24 | $982.3M | $508.9M | ||
| Q2 24 | $917.7M | $530.5M | ||
| Q1 24 | $853.3M | $543.7M |
负债/权益比KRYSRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.5M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $75.4M | $891.0K |
| 自由现金流率自由现金流/营收 | 70.4% | 1.6% |
| 资本支出强度资本支出/营收 | 2.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 1.51× | 3.65× |
| 过去12个月自由现金流最近4个季度 | $188.9M | $14.9M |
8季度趋势，按日历期对齐
经营现金流KRYSRGS
| Q4 25 | $77.5M | $1.7M | ||
| Q3 25 | $39.7M | $2.3M | ||
| Q2 25 | $52.7M | $6.8M | ||
| Q1 25 | $31.0M | $6.2M | ||
| Q4 24 | $52.8M | $2.1M | ||
| Q3 24 | $58.9M | $-1.3M | ||
| Q2 24 | $-4.2M | $5.1M | ||
| Q1 24 | $15.9M | $-277.0K |
自由现金流KRYSRGS
| Q4 25 | $75.4M | $891.0K | ||
| Q3 25 | $38.0M | $1.9M | ||
| Q2 25 | $50.8M | $6.2M | ||
| Q1 25 | $24.8M | $5.9M | ||
| Q4 24 | $52.0M | $1.7M | ||
| Q3 24 | $57.8M | $-1.4M | ||
| Q2 24 | $-5.3M | $5.1M | ||
| Q1 24 | $14.6M | $-326.0K |
自由现金流率KRYSRGS
| Q4 25 | 70.4% | 1.6% | ||
| Q3 25 | 38.8% | 3.2% | ||
| Q2 25 | 52.9% | 10.3% | ||
| Q1 25 | 28.1% | 10.3% | ||
| Q4 24 | 57.1% | 3.6% | ||
| Q3 24 | 69.0% | -3.0% | ||
| Q2 24 | -7.5% | 10.3% | ||
| Q1 24 | 32.3% | -0.7% |
资本支出强度KRYSRGS
| Q4 25 | 2.0% | 1.4% | ||
| Q3 25 | 1.7% | 0.7% | ||
| Q2 25 | 2.0% | 0.9% | ||
| Q1 25 | 7.0% | 0.6% | ||
| Q4 24 | 0.9% | 0.9% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% | ||
| Q1 24 | 2.8% | 0.1% |
现金转化率KRYSRGS
| Q4 25 | 1.51× | 3.65× | ||
| Q3 25 | 0.50× | 1.68× | ||
| Q2 25 | 1.38× | 0.06× | ||
| Q1 25 | 0.87× | 24.80× | ||
| Q4 24 | 1.16× | 0.28× | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | -0.27× | 0.06× | ||
| Q1 24 | 17.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRYS
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
